Sutro Biopharma (STRO) Retained Earnings (2017 - 2025)
Sutro Biopharma (STRO) reported Retained Earnings of -$978.0 million for Q4 2025, down 24.29% on a YoY basis from -$1.3 billion in Q4 2024, and down 5.03% sequentially from -$931.2 million in Q3 2025.
Sutro Biopharma (STRO) Retained Earnings (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of Retained Earnings data on file, last reported at -$978.0 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 24.29% year-over-year to -$978.0 million; the trailing twelve-month figure through Dec 2025 stood at -$978.0 million (down 24.29% YoY), and the FY2025 full-year result was -$978.0 million, down 24.29% from the prior year.
- Retained Earnings retreated to -$978.0 million in Q4 2025, from -$931.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $106000.0 in Q3 2024 to a low of -$978.0 million in Q4 2025.
- A 5-year average of -$349.3 million and a median of -$261.3 million in 2021 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings jumped 1414.29% in 2024 and tumbled 878583.96% in 2025, its largest moves.
- Tracing STRO's Retained Earnings over 5 years: stood at -$314000.0 in 2021, then plunged by 144044.9% to -$452.6 million in 2022, then declined by 23.59% to -$559.4 million in 2023, then tumbled by 40.66% to -$786.9 million in 2024, then retreated by 24.29% to -$978.0 million in 2025.
- Business Quant data shows STRO's Retained Earnings at -$978.0 million in Q4 2025, -$931.2 million in Q3 2025, and -$874.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -978.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -978.00 Mn |
| Sep 30, 2025 | -931.19 Mn |
| Jun 30, 2025 | -874.30 Mn |
| Mar 31, 2025 | -862.84 Mn |
| Dec 31, 2024 | -786.87 Mn |
| Sep 30, 2024 | 106,000.00 |
| Jun 30, 2024 | -163,000.00 |
| Mar 31, 2024 | -617.62 Mn |
| Dec 31, 2023 | -559.41 Mn |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 16,000.00 |
| Mar 31, 2023 | -107,000.00 |
| Dec 31, 2022 | -452.62 Mn |
| Sep 30, 2022 | -1.34 Mn |
| Jun 30, 2022 | -398.50 Mn |
| Mar 31, 2022 | -1.15 Mn |
| Dec 31, 2021 | -314,000.00 |
| Sep 30, 2021 | -30,000.00 |
| Jun 30, 2021 | -264.38 Mn |
| Mar 31, 2021 | -258.23 Mn |